{"entity":{"type":"insider","cik":"0001740847","url":"/insider/0001740847","json_url":"/insider/0001740847.json","name":"Giraudo Bryan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":16,"first":"2018-05-17","last":"2026-05-11","span_basis":"filed_date"},"name_variants":[{"name":"Giraudo Bryan","source":"filing","n_filings":16,"first_seen":"2018-05-17","last_seen":"2026-05-11"}],"transactions":[{"id":5942595,"accession":"0001104659-26-058860","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-26-058860","line_url":"/filing/0001104659-26-058860","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11130.0,"shares_display":"11,130","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":1113000.0,"total_display":"1,113,000.00","total_whole":"1,113,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-08","filed_date":"2026-05-11","scope":"insider","n_lines":2},{"id":5942591,"accession":"0001104659-26-058860","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-058860","line_url":"/filing/0001104659-26-058860","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48000.0,"shares_display":"48,000","price_per_share":100.1225,"price_display":"100.12","price_state":"stated","total_value":4805880.0,"total_display":"4,805,880.00","total_whole":"4,805,880","shares_owned_after":27825.0,"shares_owned_after_display":"27,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider","n_lines":2},{"id":2366625,"accession":"0001728117-24-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-24-000073","line_url":"/filing/0001728117-24-000073#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (COO/CFO)","role_mark":"O","role_mark_label":"Officer (COO/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO/CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.5911,"price_display":"0.59","price_state":"stated","total_value":59110.0,"total_display":"59,110.00","total_whole":"59,110","shares_owned_after":480010.0,"shares_owned_after_display":"480,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":3139028,"accession":"0001728117-24-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-24-000039","line_url":"/filing/0001728117-24-000039#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (COO/CFO)","role_mark":"O","role_mark_label":"Officer (COO/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO/CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6430.0,"shares_display":"6,430","price_per_share":1.1556,"price_display":"1.16","price_state":"stated","total_value":7430.508,"total_display":"7,430.51","total_whole":"7,431","shares_owned_after":92737.0,"shares_owned_after_display":"92,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-28","scope":"insider"},{"id":8181836,"accession":"0001728117-23-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-23-000136","line_url":"/filing/0001728117-23-000136#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (COO/CFO)","role_mark":"O","role_mark_label":"Officer (COO/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO/CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":0.5644,"price_display":"0.56","price_state":"stated","total_value":112880.0,"total_display":"112,880.00","total_whole":"112,880","shares_owned_after":380010.0,"shares_owned_after_display":"380,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-14","scope":"insider"},{"id":8662623,"accession":"0001728117-23-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-23-000032","line_url":"/filing/0001728117-23-000032#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (COO/CFO)","role_mark":"O","role_mark_label":"Officer (COO/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO/CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":1.0199,"price_display":"1.02","price_state":"stated","total_value":56094.5,"total_display":"56,094.50","total_whole":"56,095","shares_owned_after":125990.0,"shares_owned_after_display":"125,990","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":8307134,"accession":"0001728117-23-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-23-000020","line_url":"/filing/0001728117-23-000020#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (COO/CFO)","role_mark":"O","role_mark_label":"Officer (COO/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO/CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.9687,"price_display":"0.97","price_state":"stated","total_value":48435.0,"total_display":"48,435.00","total_whole":"48,435","shares_owned_after":70990.0,"shares_owned_after_display":"70,990","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-22","scope":"insider"},{"id":6525863,"accession":"0001728117-22-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-22-000061","line_url":"/filing/0001728117-22-000061#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (COO/CFO)","role_mark":"O","role_mark_label":"Officer (COO/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO/CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13869.0,"shares_display":"13,869","price_per_share":7.21,"price_display":"7.21","price_state":"stated","total_value":99995.49,"total_display":"99,995.49","total_whole":"99,995","shares_owned_after":20990.0,"shares_owned_after_display":"20,990","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-15","scope":"insider"},{"id":6989281,"accession":"0001728117-22-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-22-000029","line_url":"/filing/0001728117-22-000029#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (COO/CFO)","role_mark":"O","role_mark_label":"Officer (COO/CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO/CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10722.0,"shares_display":"10,722","price_per_share":8.915,"price_display":"8.92","price_state":"stated","total_value":95586.63,"total_display":"95,586.63","total_whole":"95,587","shares_owned_after":99167.0,"shares_owned_after_display":"99,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-23","filed_date":"2022-03-24","scope":"insider"},{"id":4836014,"accession":"0001728117-21-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001728117-21-000031","line_url":"/filing/0001728117-21-000031#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5490.0,"shares_display":"5,490","price_per_share":9.4801,"price_display":"9.48","price_state":"stated","total_value":52045.749,"total_display":"52,045.75","total_whole":"52,046","shares_owned_after":109889.0,"shares_owned_after_display":"109,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-23","filed_date":"2021-03-25","scope":"insider"},{"id":2689997,"accession":"0001209191-20-054839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-054839","line_url":"/filing/0001209191-20-054839#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":10.012,"price_display":"10.01","price_state":"stated","total_value":30036.0,"total_display":"30,036.00","total_whole":"30,036","shares_owned_after":7121.0,"shares_owned_after_display":"7,121","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-14","scope":"insider"},{"id":2881171,"accession":"0001209191-20-038515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038515","line_url":"/filing/0001209191-20-038515#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":12.9612,"price_display":"12.96","price_state":"stated","total_value":25922.4,"total_display":"25,922.40","total_whole":"25,922","shares_owned_after":4121.0,"shares_owned_after_display":"4,121","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-23","scope":"insider"},{"id":7981086,"accession":"0001209191-19-058853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058853","line_url":"/filing/0001209191-19-058853#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":5.7025,"price_display":"5.70","price_state":"stated","total_value":45620.0,"total_display":"45,620.00","total_whole":"45,620","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-03","scope":"insider"},{"id":8240696,"accession":"0001209191-19-050863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050863","line_url":"/filing/0001209191-19-050863#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1121.0,"shares_display":"1,121","price_per_share":16.7798,"price_display":"16.78","price_state":"stated","total_value":18810.1558,"total_display":"18,810.16","total_whole":"18,810","shares_owned_after":2121.0,"shares_owned_after_display":"2,121","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-26","filed_date":"2019-09-26","scope":"insider"},{"id":8297737,"accession":"0001209191-19-033844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-033844","line_url":"/filing/0001209191-19-033844#line-1","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":18.7,"price_display":"18.70","price_state":"stated","total_value":18700.0,"total_display":"18,700.00","total_whole":"18,700","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-06-03","scope":"insider"},{"id":8311742,"accession":"0001209191-19-009430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-009430","line_url":"/filing/0001209191-19-009430#line-2","is_derivative":false,"issuer_cik":"0001728117","issuer_name":"Gossamer Bio, Inc.","issuer_ticker":"GOSS","issuer_name_source":null,"issuer_url":"/issuer/0001728117","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":96000.0,"total_display":"96,000.00","total_whole":"96,000","shares_owned_after":23879.0,"shares_owned_after_display":"23,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-12","scope":"insider"},{"id":6519349,"accession":"0001209191-18-031121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-031121","line_url":"/filing/0001209191-18-031121#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001740847","owner_name":"Giraudo Bryan","owner_display_name":"Giraudo Bryan","owner_url":"/insider/0001740847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.4566,"price_display":"6.46","price_state":"stated","total_value":64566.0,"total_display":"64,566.00","total_whole":"64,566","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2018-05-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Director","n_filings":3,"first_seen":"2018-05-17","last_seen":"2026-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001728117","name":"Gossamer Bio, Inc.","url":"/issuer/0001728117","role":"Officer (COO/CFO)","n_filings":13,"first_seen":"2019-02-12","last_seen":"2024-06-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001740847","retrieved_at":"2026-08-24T23:19:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}